Trouble swallowing, chronic nausea and irritable bowel syndrome also predict future development of Parkinson’s disease. To be clear, any one of these signs isn’t a definite marker of disease (I mean, ...

Parkinson’s Alert Dogs, a local non-profit, has recently released astonishing research. In 2016, PADs became the only program ...

Individuals with vs without Parkinson disease more frequently had cutaneous malignant melanoma, whereas basal cell carcinoma, actinic keratosis, and non-melanoma skin cancer were more frequent in ...

If you find yourself sleepy during your daily activities in your older age, you may need to consider it more than an inconvenience — since the fatigue may indicate you're at higher risk for developing ...

Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a study published in ...

Brain disorders like Parkinson's disease (PD) or Alzheimer's disease (AD) start to develop in patients much earlier than when ...

Leading neurologists and movement disorder specialists have made submissions to the Australian chemical regulator calling for a ban on paraquat, over its links with Parkinson's disease.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Parkinson’s disease (PD) is a progressive disorder of the nervous system. It primarily affects movement but can also lead to other symptoms, significantly impacting quality of life over time.

What is glycogen storage disease in children? Glycogen storage disease (GSD) is a rare condition that changes the way the body uses and stores glycogen, a form of sugar or glucose. Glycogen is a main ...

A Rutgers Health study has found that people who took multiple courses of penicillin antibiotics had a modestly lower risk of developing Parkinson's disease, a surprising finding that researchers ...

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...